Clinical Trials Browser

Phase 3 × Active not recruiting × ivosidenib × Clear all

NCT03173248 2025-11-10

AGILE

Phase 3 Active not recruiting

146 enrolled 11 charts 1 FDA

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT03839771 2024-10-02

HOVON150AML

Phase 3 Active not recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute